Pharmaceutical Preparations · CIK 1867096
Develops and commercializes therapies for chronic endocrine and neurological diseases using proprietary formulation technology
Comparable business profile · signals at a glance
Coverage (30d): 1 reputable article.
Reputable outlets only (Reuters, WSJ, CNBC, Barron's, and peers). More on Google News ↗
In the 90 days to Mar 2, 2026: 5 sold $1.7M.
| Date | Insider | Action | Shares | Price | Value |
|---|---|---|---|---|---|
| Mar 2, 2026 | Hecht BethSee Remarks | Sell | 16,567 | $6.24 | $103K |
| Mar 2, 2026 | Hecht BethSee Remarks | Sell | 100 | $7.06 | $706 |
| Feb 2, 2026 | Hecht BethSee Remarks | Sell | 16,667 | $7.45 | $124K |
| Jan 8, 2026 | Mcculloch KevinSee Remarks | Sell | 15,000 | $8.00 | $120K |
| Jan 5, 2026 | Shannon John Patrick JrSee Remarks | Sell | 24,907 | $7.08 | $176K |
| Jan 2, 2026 | Hecht BethSee Remarks | Sell | 16,667 | $7.43 | $124K |
| Dec 19, 2025 | Johnson JohnDirector | Sell | 135,400 | $7.22 | $978K |
| Dec 12, 2025 | Bormann-Kennedy Barbara-Jean AnneDirector | Sell | 15,000 | $7.09 | $106K |
| Dec 1, 2025 | Hecht BethSee Remarks | Sell | 16,667 | $7.01 | $117K |
| Nov 13, 2025 | Shannon John Patrick JrSee Remarks | Sell | 23,242 | $7.46 | $173K |
| Nov 11, 2025 | Hecht BethSee Remarks | Sell | 16,667 | $7.40 | $123K |
Open-market buys & sells (Form 4, transaction codes P/S). Source: SEC structured insider data.